The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle

被引:179
作者
Matsuda, C
Hayashi, YK
Ogawa, M
Aoki, M
Murayama, K
Nishino, I
Nonaka, I
Arahata, K
Brown, RH [1 ]
机构
[1] Massachusetts Gen Hosp E, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA
[2] AIST, Neurosci Res Inst, Mol Neurobiol Grp, Tsukuba, Ibaraki 3058566, Japan
[3] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan
[4] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan
[5] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo 1878502, Japan
关键词
D O I
10.1093/hmg/10.17.1761
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dysferlin is a surface membrane protein in skeletal muscle whose deficiency causes distal and proximal, recessively inherited, forms of muscular dystrophy designated Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B), respectively. The function of dysferlin is not defined. Caveolin-3 is another skeletal muscle membrane protein which is important in the formation of caveolae and whose mutations cause dominantly inherited limb girdle muscular dystrophy type 1C (LGMD1C). We report that dysferlin co-immunoprecipitates with caveolin-3 from biopsied normal human skeletal muscles. We also describe abnormal localization of dysferlin in muscles from patients with LGMD1C including novel missense mutation (T64P) in the human caveolin-3 gene (CAV3). The immunoprecipitation data are consistent with the parallel observation that dysferlin immunostaining is not normal in LGMD1C muscles. Amino acid sequence analysis of the dysferlin protein reveals seven sites that correspond to caveolin-3 scaffold-binding motifs, and one site that is a potential target to bind the WW domain of the caveolin-3 protein. This is the first description of a possible dysferlin interacting protein; it suggests the hypothesis that one function of dysferlin may be to interact with caveolin-3 to subserve signaling functions of caveolae.
引用
收藏
页码:1761 / 1766
页数:6
相关论文
共 25 条
[1]   Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies) [J].
Anderson, LVB ;
Harrison, RM ;
Pogue, R ;
Vafiadaki, E ;
Pollitt, C ;
Davison, K ;
Moss, JA ;
Keers, S ;
Pyle, A ;
Shaw, PJ ;
Mahjneh, I ;
Argov, Z ;
Greenberg, CR ;
Wrogemann, K ;
Bertorini, T ;
Goebel, HH ;
Beckmann, JS ;
Bashir, R ;
Bushby, KMD .
NEUROMUSCULAR DISORDERS, 2000, 10 (08) :553-559
[2]   Dysferlin is a plasma membrane protein and is expressed early in human development [J].
Anderson, LVB ;
Davison, K ;
Moss, JA ;
Young, C ;
Cullen, MJ ;
Walsh, J ;
Johnson, MA ;
Bashir, R ;
Britton, S ;
Keers, S ;
Argov, Z ;
Mahjneh, I ;
Fougerousse, F ;
Beckmann, JS ;
Bushby, KMD .
HUMAN MOLECULAR GENETICS, 1999, 8 (05) :855-861
[3]  
AOKI M, 2001, IN PRESS NEUROLOGY
[4]  
Arahata K, 2000, NEUROPATHOLOGY, V20, pS34
[5]   A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B [J].
Bashir, R ;
Britton, S ;
Strachan, T ;
Keers, S ;
Vafiadaki, E ;
Lako, M ;
Richard, I ;
Marchand, S ;
Bourg, N ;
Argov, Z ;
Sadeh, M ;
Mahjneh, I ;
Marconi, G ;
Passos-Bueno, MR ;
Moreira, ED ;
Zatz, M ;
Beckmann, JS ;
Bushby, K .
NATURE GENETICS, 1998, 20 (01) :37-42
[6]   The third human FER-1-like protein is highly similar to dysferlin [J].
Britton, S ;
Freeman, T ;
Vafiadaki, E ;
Keers, S ;
Harrison, R ;
Bushby, K ;
Bashir, R .
GENOMICS, 2000, 68 (03) :313-321
[7]   Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia [J].
Carbone, I ;
Bruno, C ;
Sotgia, F ;
Bado, M ;
Broda, P ;
Masetti, E ;
Panella, A ;
Zara, F ;
Bricarelli, FD ;
Cordone, G ;
Lisanti, MP ;
Minetti, C .
NEUROLOGY, 2000, 54 (06) :1373-1376
[8]   Identification of peptide and protein ligands for the caveolin-scaffolding domain - Implications for the interaction of caveolin with caveolae-associated proteins [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Ikezu, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6525-6533
[9]   Myoferlin, a candidate gene and potential modifier of muscular dystrophy [J].
Davis, DB ;
Delmonte, AJ ;
Ly, CT ;
McNally, EM .
HUMAN MOLECULAR GENETICS, 2000, 9 (02) :217-226
[10]   DEFICIENCY OF A GLYCOPROTEIN COMPONENT OF THE DYSTROPHIN COMPLEX IN DYSTROPHIC MUSCLE [J].
ERVASTI, JM ;
OHLENDIECK, K ;
KAHL, SD ;
GAVER, MG ;
CAMPBELL, KP .
NATURE, 1990, 345 (6273) :315-319